RALEIGH, N.C., Dec. 5, 2001 (PRIMEZONE) -- Molecular Mining Corporation (MMC) today announced a collaborative agreement with NextGen Sciences Ltd. in the area of protein biochips.
Molecular Mining Corporation (MMC) and NextGen Sciences Ltd. (NextGen) have agreed to collaborate in the area of protein biochips. The scope of the collaborative agreement adapts the companies' respective products for optimal integration and productivity and co-promotes their products.
NextGen has organized a Consortium from industry and academia that includes major players in Disposables, Fluidics, LIMS Systems and Data Mining to take an end-to-end approach to fabricating and selling protein biochips for important applications in Life Science. Other consortium members include Nunc A/S, Avidity, Harvard Biosciences and Thermo LabSystems.
Adaptation of Molecular Mining Corporation's GeneLinker gene expression analysis software family will enable the use of the Consortium's offerings in the emerging protein biochip arena. This is made possible by MMC's experience gained with DNA biochips and NextGen's experience in the development and production of protein biochips. This collaboration will give MMC important information regarding the future needs for protein biochip data mining in the protein biochip field. NextGen and its academic partner, the University of Cambridge, will use the MMC GeneLinker software system in-house to run and support NextGen studies.
"The combination of high performance analysis and exploratory value of our gene expression analysis software, and our unparalleled easy upgrade path to more sophisticated solutions for inference of relationships between genes and predictive in silico models yields a winning combination for NextGen and MMC customers," statedDr. Roland Somogyi, MMC's Chief Scientific Officer.
"We expect protein biochip users to see this collaboration as the first step in a long relationship with NextGen and MMC in the emerging field of protein biochip data mining," said NextGen Sciences' CEO, Dr. Kevin Auton. "Managing the data from these systems is a nightmare unless you have your information systems together from the start."
Molecular Mining Corporation specializes in the exploration, inference and prediction of molecular networks derived from gene expression, proteomics and SNPs (single nucleotide polymorphisms) data, and the application of these network models to diagnostic and drug target identification, predictive toxicology and in silico drug screening.